earnings
confidence high
sentiment negative
materiality 0.60
KORU Medical Q2 net revenue $5.5M; net loss $1.1M; sequential growth of 2%
KORU Medical Systems, Inc.
2021-Q2 EPS reported
-$0.05
revenue$10,959,125
- Net revenue of $5.5 million, down 28.3% YoY but up 2% sequentially.
- Gross margin 58.1%, down 5.6 ppts YoY due to lower volumes.
- Net loss of $1.1 million ($0.03 diluted loss per share).
- Non-GAAP adjusted EBITDA of $(0.3) million vs $1.8 million in Q2 2020.
- Mid-single-digit growth in domestic immunoglobulin market and specialty pharmacy channel indicates market recovery.